Lydia Benitez

If you didn't get enough onc stewardship from @WolverHeme checkout our newest pub! Proud of @maddyochs and grateful to be part of #teambadblood with @Berninini @ajperissinotti @kristenpettitmd et al. link.springer.com/article/10.100…

Step inside from the polar vortex 🥶, grab a drink ☕️🥂, and listen to our latest episode - "Navigating a BlinatumoMAD World" 🤪 @ajperissinotti @Berninini @Lydialbc #blinatumomab #leusm creators.spotify.com/pod/show/wolve…

If you are a hem/onc pharmacist and have ever felt de-valued by the metrics that capture your work you’ve got to fill out this survey!!! Thanks in advance for responding and helping make a difference to improve onc workforce retention! instagram.com/p/DE5U_O_s85_/…

Support Nona's Journey to Recovery gofund.me/7d393599

Check out our #HERO consortium poster 4267 TODAY at #ASH23! We compared ATRA+ATO+GO vs ATRA+ATO+Ida in HR APL 🩸In real world, 69% of the GO arm required ida for cytoreduction (so not truly chemo free) 🩸🟰 efficacy 🩸🟰 composite safety, but ⬇️ duration of neutropenia in GO arm

Check out outcomes of our approach for ALL using individualized pegasparaginase dosing & monitoring! 🎉 Proud of @tay_coe14 and #teambadblood @Berninini @ajperissinotti @kristenpettitmd and twitterless Patrick Burke and Dale Bixby! rb.gy/0hva3

Listen to "All too well: the reality of leukemia treatment"! In an extra special episode, @ajperissinotti @Berninini and @Lydialbc discuss the ALL treatment journey with a former patient, Madeline! A must-listen for anyone who takes care of AYA patients! spotifyanchor-web.app.link/e/8UWGLS85sAb

Seeing some problematic leukemia takes lately… We should NOT be abandoning phase III trials or changing practice based on single-institution/arm data. There are countless examples of approaches that look promising in phase II / single-center studies that can’t be replicated!

Congrats to these rockstars for becoming HOPA Fellows! Strong work ladies! @kczmj @kamakshi_rao @ila_m_saunders #HOPAAC2023

Listen to "Episode 13: You get blinatumomab! You get blinatumomab!" where we talk about Oprah's favorite drug! Here, @Lydialbc and the Twitterless Patrick Burke help us decide whether the ECOG1910 trial is practice changing! Should MRD- patients get blin? anchor.fm/wolverheme/epi…

@KyleGrose9 @Berninini @WolverHeme @FirasElChaer The fact we do not know this answer is the reason we try our best NOT to switch. There are no good clinical data to say outcomes will be preserved if we switch to Erwinia/Rylaze. The observational data have significant confounders. We do graded challenge with PEG and TDM.

This makes me so annoyed. How can you claim to be concerned about equity and access, then claim an event that will cost a student $1k+ is a “can’t miss”! Programs and candidates need to align and evolve. No way 900 programs should be traveling cross country for this. Do better.

@justinhreid I hear you and you are not alone. It’s really unfortunate that we always feel like the only things we can cut out are the things we enjoy the most. At some point the career we trained so hard for becomes unrecognizable

Phenomenal @atoppsummit talk on the #GreatMigration of Oncology Pharmacists out of clinical practice by @AlisonGulbis, @kamakshi_rao, @kczmj! Over ❗️2/3❗️considering a career change. Our work environments seem to be as toxic ☢️ as the chemo we give. How can we fix this???

Grateful for the opportunity to sit down and chat with our #teambadblood about the importance of onc stewardship in AML. Also some excellent recs on 🥃🐎.@Berninini @ajperissinotti @maddyochs

Sunny San Diego + 🔥 moderator @Berninini ... hope this #AML debate between @Lydialbc and Caitlin Rausch doesn't get too heated! #oncopharm #data #MedTwitter

MOOD! 〽️⛳️ | #GoBlue

WASH-MICH-TX-KY-NC-NY... BIG things coming your way oncopharm #HOPAAC22

Shout out to the wonderful pharmDs who made this multi center collab possible!!! @berninini @anthonyperissi2 #teambadblood and @KLratermann @SClarkPharmD & other superstar collaborators #oncstewardship @UMichPharmacy